Bionomics Ltd (OTCMKTS:BNOEF)’s share price shot up 69% during mid-day trading on Tuesday . The company traded as high as $0.07 and last traded at $0.07, 2,000 shares were traded during mid-day trading. An increase of 18% from the average session volume of 1,700 shares. The stock had previously closed at $0.04.
A number of equities research analysts recently weighed in on the stock. HC Wainwright raised shares of Bionomics from a “neutral” rating to a “buy” rating in a research note on Thursday, September 26th. Zacks Investment Research downgraded shares of Bionomics from a “buy” rating to a “hold” rating in a research note on Wednesday, July 17th.
The firm’s fifty day moving average price is $0.06 and its 200-day moving average price is $0.05.
Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancer in Australia, France, and the United States. It operates through Drug Discovery and Development, and Contract Services segments.
Further Reading: How interest rates affect municipal bond prices
Receive News & Ratings for Bionomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionomics and related companies with MarketBeat.com's FREE daily email newsletter.